Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Workman

Showing results (261-270 of 268) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 268 results.
Leukemia|August 13, 2010
Targeting heat shock protein 72 enhances Hsp90 inhibitor-induced apoptosis in myelomaE L Davenport, A Zeisig, L I Aronson, et al.
Analytical Biochemistry|February 8, 2006
A fluorescence polarization assay for inhibitors of Hsp90R Howes, X Barril, B W Dymock, et al.
British Journal of Cancer|November 26, 2009
A phase I study of the nitroimidazole hypoxia marker SR4554 using 19F magnetic resonance spectroscopyC P Lee, G S Payne, A Oregioni, et al.
Leukemia|February 23, 2012
Selective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patternsA S Moore, A Faisal, D Gonzalez de Castro, et al.
British Journal of Cancer|May 27, 2010
Guidelines for the welfare and use of animals in cancer researchP Workman, E O Aboagye, F Balkwill, et al.
Blood Cancer Journal|April 1, 2017
Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle controlC Pawlyn, M D Bright, A F Buros, et al.
The British Journal of Radiology|October 1, 2004
Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trialsM O Leach, K M Brindle, J L Evelhoch, et al.
British Journal of Cancer|May 5, 2005
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendationsM O Leach, K M Brindle, J L Evelhoch, et al.
Pageof 27

Showing results (261-270 of 268) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 268 results.
Leukemia|August 13, 2010
Targeting heat shock protein 72 enhances Hsp90 inhibitor-induced apoptosis in myelomaE L Davenport, A Zeisig, L I Aronson, et al.
Analytical Biochemistry|February 8, 2006
A fluorescence polarization assay for inhibitors of Hsp90R Howes, X Barril, B W Dymock, et al.
British Journal of Cancer|November 26, 2009
A phase I study of the nitroimidazole hypoxia marker SR4554 using 19F magnetic resonance spectroscopyC P Lee, G S Payne, A Oregioni, et al.
Leukemia|February 23, 2012
Selective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patternsA S Moore, A Faisal, D Gonzalez de Castro, et al.
British Journal of Cancer|May 27, 2010
Guidelines for the welfare and use of animals in cancer researchP Workman, E O Aboagye, F Balkwill, et al.
Blood Cancer Journal|April 1, 2017
Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle controlC Pawlyn, M D Bright, A F Buros, et al.
The British Journal of Radiology|October 1, 2004
Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trialsM O Leach, K M Brindle, J L Evelhoch, et al.
British Journal of Cancer|May 5, 2005
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendationsM O Leach, K M Brindle, J L Evelhoch, et al.
Pageof 27